Personal information

Other IDs

Scopus Author ID: 55212347600

Keywords

Nanomedicine, Nanotechnology, Pharmaceutics, Pharmacology, Biotechnology, enterpreneur

Countries

South Africa

Activities

Collapse all

Employment (1)

Nelson Mandela University: Gqeberha , South Africa , ZA

2021-10-01 to present | Research Chair in Nanomedicine
Employment
Source: Self-asserted source
Maluta Steven Mufamadi

Education and qualifications (1)

University of the Witwatersrand: Johannesburg, Gauteng , ZA

2011-02-01 to 2015-07-15 | PhD (Pharmacy and Pharmacology )
Education
Source: Self-asserted source
Maluta Steven Mufamadi

Works (22)

Microfluidic electrochemical biosensors: tools for advancing the sustainable development goals

Trends in Biotechnology
2024-10 | Journal article
DOI: 10.1016/j.tibtech.2024.04.005
Contributors: Mkliwa Koumbia; Mpho Ngoepe; Joseph Benjamin Holman; Maluta Steven Mufamadi; Madoka Takai
Source: check_circle
Crossref

Efficient detection and treatment of pharmaceutical contaminants to produce clean water for better health and environmental

Journal of Cleaner Production
2023-02 | Journal article
DOI: 10.1016/j.jclepro.2022.135798
Contributors: Mokgehle R. Letsoalo; Thandiwe Sithole; Steven Mufamadi; Zvanaka Mazhandu; Mika Sillanpaa; Ajeet Kaushik; Tebogo Mashifana
Source: check_circle
Crossref

Next‐Generation Vaccines: Nanovaccines in the Fight against SARS‐CoV‐2 Virus and beyond SARS‐CoV‐2

BioMed Research International
2023-01 | Journal article
DOI: 10.1155/2023/4588659
Contributors: Maluta Steven Mufamadi; Mpho Phehello Ngoepe; Ofentse Nobela; Nhlanhla Maluleke; Bafedile Phorah; Banele Methula; Thapelo Maseko; Dipuo Ingrid Masebe; Hazel Tumelo Mufhandu; Lebogang Maureen Katata-Seru et al.
Source: check_circle
Crossref

Potential of Azadirachta indica as a Capping Agent for Antiviral Nanoparticles against SARS-CoV-2

BioMed Research International
2022 | Journal article
DOI: 10.1155/2022/5714035
EID:

2-s2.0-85138665298

Part of ISSN: 23146141 23146133
Contributors: Foka, F.E.T.; Manamela, N.; Mufamadi, S.M.; Mufhandu, H.T.
Source: Self-asserted source
Maluta Steven Mufamadi via Scopus - Elsevier

Nano-Enabled Chronic Wound Healing Strategies: Burn and Diabetic Ulcer Wounds

Journal of Biomedical Nanotechnology
2022-09-01 | Journal article
DOI: 10.1166/jbn.2022.3427
Part of ISSN: 1550-7033
Contributors: Mpho Phehello Ngoepe; Aidan Battison; Steven Mufamadi
Source: Self-asserted source
Maluta Steven Mufamadi

Applications of Nanoparticles for Herpes Simplex Virus (HSV) and Human Immunodeficiency Virus (HIV) Treatment

Journal of biomedical nanotechnology
2021 | Journal article
DOI: 10.1166/jbn.2021.3074
EID:

2-s2.0-85120504699

Part of ISSN: 15507033
Contributors: Obisesan, O.; Katata-Seru, L.; Mufamadi, S.; Mufhandu, H.
Source: Self-asserted source
Maluta Steven Mufamadi via Scopus - Elsevier

Bioengineering of Inorganic Nanoparticle Using Plant Materials to Fight Extensively Drug-Resistant Tuberculosis

Green Synthesis in Nanomedicine and Human Health
2021-01-29 | Book chapter
DOI: 10.1201/9781003023197-12
Part of ISBN: 9781003023197
Contributors: Mpho Phehello Ngoepe; Maluta Steven Mufamadi
Source: Self-asserted source
Maluta Steven Mufamadi

Cancer Nanotheranostics

Green Synthesis in Nanomedicine and Human Health
2021-01-29 | Book chapter
DOI: 10.1201/9781003023197-3
Part of ISBN: 9781003023197
Contributors: Maluta Steven Mufamadi; Marian Jiya John; Mpho Phehello Ngoepe; Palesa Rose Sekhejane
Source: Self-asserted source
Maluta Steven Mufamadi

Nanotechnology shows promise for next-generation vaccines in the fight against COVID-19

MRS Bulletin
2020 | Journal article
DOI: 10.1557/mrs.2020.307
EID:

2-s2.0-85097860310

Part of ISSN: 08837694
Contributors: Mufamadi, M.S.
Source: Self-asserted source
Maluta Steven Mufamadi via Scopus - Elsevier

Cancer Bionanotechnology: Biogenic Synthesis of Metallic Nanoparticles and Their Pharmaceutical Potency

Nanotechnology in the Life Sciences
2019 | Book chapter
DOI: 10.1007/978-3-030-16383-9_10
EID:

2-s2.0-85101637404

Part of ISSN: 25238035 25238027
Contributors: Mufamadi, M.S.; George, J.; Mazibuko, Z.; Tshikalange, T.E.
Source: Self-asserted source
Maluta Steven Mufamadi via Scopus - Elsevier

From lab to market: Strategies to nanotechnology commercialization in Africa

MRS Bulletin
2019 | Journal article
DOI: 10.1557/mrs.2019.134
EID:

2-s2.0-85066975451

Part of ISSN: 08837694
Contributors: Mufamadi, M.S.
Source: Self-asserted source
Maluta Steven Mufamadi via Scopus - Elsevier

Green Engineering of Silver Nanoparticles to Combat Plant and Foodborne Pathogens: Potential Economic Impact and Food Quality

Nanotechnology in the Life Sciences
2019 | Book chapter
DOI: 10.1007/978-3-030-16379-2_16
EID:

2-s2.0-85101641025

Part of ISSN: 25238035 25238027
Contributors: Mufamadi, M.S.; Mulaudzi, R.B.
Source: Self-asserted source
Maluta Steven Mufamadi via Scopus - Elsevier

Liposome-embedded, polymeric scaffold for extended delivery of galantamine

Journal of Drug Delivery Science and Technology
2019 | Journal article
DOI: 10.1016/j.jddst.2019.02.001
EID:

2-s2.0-85061081232

Part of ISSN: 17732247
Contributors: Mufamadi, M.S.; Kumar, P.; du Toit, L.C.; Choonara, Y.E.; Obulapuram, P.K.; Modi, G.; Naidoo, D.; Iyuke, S.E.; Pillay, V.
Source: Self-asserted source
Maluta Steven Mufamadi via Scopus - Elsevier

Functionalized Nanolipobubbles Embedded Within a Nanocomposite Hydrogel: a Molecular Bio-imaging and Biomechanical Analysis of the System

AAPS PharmSciTech
2017 | Journal article
DOI: 10.1208/s12249-016-0541-z
EID:

2-s2.0-84969135712

Part of ISSN: 15309932
Contributors: Mufamadi, M.S.; Choonara, Y.E.; Kumar, P.; du Toit, L.C.; Modi, G.; Naidoo, D.; Iyuke, S.E.; Pillay, V.
Source: Self-asserted source
Maluta Steven Mufamadi via Scopus - Elsevier

Nanomaterial-based biosensors in agriculture application and accessibility in rural smallholding farms: Food security

Nanotechnology: An Agricultural Paradigm
2017 | Book chapter
Part of DOI: 10.1007/978-981-10-4573-8_12
EID:

2-s2.0-85033329337
Contributors: Mufamadi, M.S.; Sekhejane, P.R.
Source: Self-asserted source
Maluta Steven Mufamadi via Scopus - Elsevier

Ligand-functionalized nanoliposomes for targeted delivery of galantamine

International Journal of Pharmaceutics
2013 | Journal article
DOI: 10.1016/j.ijpharm.2013.03.037
EID:

2-s2.0-84875929828

Part of ISSN: 03785173 18733476
Contributors: Mufamadi, M.S.; Choonara, Y.E.; Kumar, P.; Modi, G.; Naidoo, D.; Van Vuuren, S.; Ndesendo, V.M.K.; Toit, L.C.D.; Iyuke, S.E.; Pillay, V.
Source: Self-asserted source
Maluta Steven Mufamadi via Scopus - Elsevier

Surface-engineered nanoliposomes by chelating ligands for modulating the neurotoxicity associated with β-amyloid aggregates of alzheimer's disease

Pharmaceutical Research
2012 | Journal article
DOI: 10.1007/s11095-012-0770-0
EID:

2-s2.0-84867841702

Part of ISSN: 07248741 1573904X
Contributors: Mufamadi, M.S.; Choonara, Y.E.; Kumar, P.; Modi, G.; Naidoo, D.; Ndesendo, V.M.K.; Du Toit, L.C.; Iyuke, S.E.; Pillay, V.
Source: Self-asserted source
Maluta Steven Mufamadi via Scopus - Elsevier

Efficient inhibition of hepatitis B virus replication in vivo, using polyethylene glycol-modified adenovirus vectors.

Human gene therapy
2008-11-01 | Journal article
DOI: 10.1089/hum.2008.066
PMID: 19848584
Contributors: Crowther C; Ely A; Hornby J; Mufamadi S; Salazar F; Marion P; Arbuthnot P
Source: Self-asserted source
Maluta Steven Mufamadi

Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo.

Molecular therapy : the journal of the American Society of Gene Therapy
2008-04-22 | Journal article
DOI: 10.1038/mt.2008.82
PMID: 18431360
Contributors: Ely A; Naidoo T; Mufamadi S; Crowther C; Arbuthnot P
Source: Self-asserted source
Maluta Steven Mufamadi

Specific inhibition of HBV replication in vitro and in vivo with expressed long hairpin RNA.

Molecular therapy : the journal of the American Society of Gene Therapy
2007-01-09 | Journal article
DOI: 10.1038/sj.mt.6300077
PMID: 17213835
Contributors: Marc Weinberg; Ely A; Barichievy S; Crowther C; Mufamadi S; Sergio Carmona; Arbuthnot P
Source: Self-asserted source
Maluta Steven Mufamadi

Effective anti-hepatitis B virus hammerhead ribozymes derived from multimeric precursors.

Oligonucleotides
2007-01-01 | Journal article
DOI: 10.1089/oli.2006.0049
PMID: 17461767
Contributors: Marc Weinberg; Ely A; Passman M; Mufamadi SM; Arbuthnot P
Source: Self-asserted source
Maluta Steven Mufamadi

Green Synthesis in Nanomedicine and Human Health

CRC Press
Book
Contributors: Maluta Steven Mufamadi ; Rofhiwa Mulaudzi, Richard L.K. Glover, Daniel Nyanganyura
Source: Self-asserted source
Maluta Steven Mufamadi
How many people are using ORCID?